Relationship satisfaction predicts sexual activity following risk-reducing salpingo-oophorectomy

Journal of Psychosomatic Obstetrics and Gynecology

Volumn 35, Issue 2, 2014, Pages 62-68

  Lorenz, Tierney ^a   McGregor, Bonnie ^b   Swisher, Elizabeth ^b  

^a INDIANA UNIVERSITY   (United States)

^b USA   (United States)

Author keywords

Cancer; Prophylactic oophorectomy; Quality of life; Sexual activity; Sexual function; Women

Indexed keywords

ADULT; ANXIETY; ARTICLE; DEPRESSION; FEMALE; HEALTH STATUS; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENTAL HEALTH; OUTCOME ASSESSMENT; OVARY CANCER; PATIENT COUNSELING; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SALPINGOOOPHORECTOMY; SECONDARY ANALYSIS; SELF REPORT; SEXUAL BEHAVIOR; SEXUAL SATISFACTION; ETIOLOGY; MIDDLE AGED; OVARIAN NEOPLASMS; OVARIECTOMY; PSYCHOLOGY; SATISFACTION; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

ADULT; ANXIETY; DEPRESSION; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; OVARIECTOMY; PERSONAL SATISFACTION; QUALITY OF LIFE; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 84900870339     PISSN: 0167482X     EISSN: 17438942     Source Type: Journal    
DOI: 10.3109/0167482X.2014.899577     Document Type: Article

References (31)

1. United States Cancer Statistics: 1999-2009 Incidence and Mortality Web-based Report. Atlanta (GA): U. S. Cancer Statistics Working Group. Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2013.
2. Rebbeck TR, Kauff ND, Domchek SM. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 2009;101:80-7.
3. Madalinska JB, Hollenstein J, Bleiker E, et al. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. J Clin Oncol 2005;23:6890-8.
4. Hallowell N, Baylock B, Heiniger L, et al. kConFab Psychosocial Group on behalf of the kConFab Investigators. 2012. Looking different, feeling different: women's reactions to risk-reducing breast and ovarian surgery. Familial Cancer 2012;11:215-24.
5. Robson M, Hensley M, Barakat R, et al. Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy. Gynecol Oncol 2003;89:281-7. (Pubitemid 36457877)
6. Madalinska JB, van Beurden M, Bleiker EMA, et al. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy. J Clin Oncol 2006;24:3576-82. (Pubitemid 46630529)
7. Finch A, Metcalfe K, Chiang J, et al The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation. Gynecol Oncol 2011;121:163-8.
8. Fang CY, Cherry C, Devarajan K, et al. A prospective study of quality of life among women undergoing risk-reducing salpingooophorectomy versus gynecologic screening for ovarian cancer. Gynecol Oncol 2009;112:594-600.
9. Bradford A, Meston CM. Sexual outcomes and satisfaction with hysterectomy: influence of patient education. J Sex Med 2007;4: 106-14. (Pubitemid 46002372)
10. Michelsen TM, Dørum A, Dahl AA. A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer. Gynecol Oncol 2009;113:128-33.
11. Barlow DH. Causes of sexual dysfunction: the role of anxiety and cognitive interference. J Consult Clin Psychol 1986;54:140.
12. Baldwin DS. Depression and sexual dysfunction. Br Med Bull 2001;57:81-99. (Pubitemid 32612672)
13. Pujols Y, Meston CM, Seal BN. The association between sexual satisfaction and body image in women. J Sex Med 2010;7:905-16.
14. Leiblum SR, Koochaki PE, Rodenberg CA, et al. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS). Menopause 2006;13:46-56.
15. Bellerose SB, Binik YM. Body image and sexuality in oophorectomized women. Arch Sex Behav 1993;22:435-59. (Pubitemid 23309002)
16. McNulty JK, Fisher TD. 2008. Gender differences in response to sexual expectancies and changes in sexual frequency: a short-term longitudinal study of sexual satisfaction in newly married couples. Arch Sex Behav 2008;37:229-40. (Pubitemid 351423076)
17. Murray ML, Cerrato F, Bennett RL, Jarvik GP. 2011. Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: variant reclassification and surgical decisions. Genet Med 2011;13: 998-1005.
18. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1: 385-401.
19. Orme JG, Reis J, Herz EJ. Factorial and discriminant validity of the center for epidemiological studies depression (CES-D) scale. J Clin Psychol 1986;42:28-33. (Pubitemid 16188206)
20. Speilberger CD, Gorsuch R, Lushene R, et al. Manual for the statetrait anxiety inventory. Palo Alto, CA: Consulting Psychologists; 1983.
21. Oei TP, Evans L, Crook GM. Utility and validity of the STAI with anxiety disorder patients. Br J Clin Psychol 2011;29:429-32.
22. Ware Jr JE, Kosinski M, Bayliss MS, et al. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 1995;33:AS264-79.
23. Ganz PA, Day R, Ware JE, et al. Base-line quality-of-life assessment in the national surgical adjuvant breast and bowel project breast cancer prevention trial. J Natl Cancer Inst 1995;87: 1372-82.
24. Greendale GA, Reboussin BA, Hogan P, Barnabei VM, Shumaker S, Johnson S, Barrett-Connor E. Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstet Gynecol 1998;92: 982-8. (Pubitemid 28536116)
25. Alfano CM, McGregor BA, Kuniyuki A, et al. Psychometric properties of a tool for measuring hormome-related systoms in breast cancer survivors. Pschyo-Oncology 2006;15:985-1000. (Pubitemid 44762704)
26. Lorenz T, Stephenson KR, Meston CM. Validated questionnaires in female sexual function assessment. In: Mulhall JP, Incrocci L, Goldstein I, Rosen RC, editor. Cancer and sexual health. New York: Humana Press 2011;317-37.
27. Stephenson KR, Meston CM. Differentiating components of sexual well-being in women: are sexual satisfaction and sexual distress independent constructs? J Sex Med 2010;7:2458-68.
28. Sims KE, Meana M. Why did passion wane? A qualitative study of married women's attributions for declines in sexual desire. J Sex Marital Ther 2010;36:360-80.
29. Stephenson KR, Meston CM. When are sexual difficulties distressing for women? The selective protective value of intimate relationships. J Sex Med 2010;7:3683-94.
30. van Oostrom I, Meijers-Heijboer H, Lodder LN, et al. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. J Clin Oncol 2003;21:3867-74. (Pubitemid 46606243)
31. Lodder LN, Frets PG, Trijsburg RW, et al. One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Res Treat 2002;73:97-112. (Pubitemid 34548153) Development